Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice

Overview of attention for article published in Psychopharmacology, April 1999

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent: 9 patents

Citations

dimensions_citation: 253 Dimensions

Readers on

mendeley: 46 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 9 patents that reference this research output.

Method for treating epileptic patients with fenfluramine

Application CN-114585354-A

China

METHODS OF TREATING EPILEPTIC PATIENTS WITH FENFLURAMINE

Application WO-2021053389-A1

World Intellectual Property Organisation (WIPO)

Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators…

Application US-9067949-B2

United States of America

Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and…

Application US-8575186-B2

United States of America

Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists

Grant US-7795436-B2

United States of America

Pyrrolo(oxo)quinolines as 5HT ligands

Application US-7618980-B2

United States of America

Pyrrolo(oxo)isoquinolines as 5HT ligands

Application US-7572805-B2

United States of America

For therapy of obesity

Grant US-7238702-B2

United States of America

Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists

Grant US-7109339-B2

United States of America